{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T13:07:33Z","timestamp":1762348053407,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22376192"],"award-info":[{"award-number":["22376192"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017668","name":"Anhui Provincial Key Research and Development Plan","doi-asserted-by":"publisher","award":["2022e07020004"],"award-info":[{"award-number":["2022e07020004"]}],"id":[{"id":"10.13039\/501100017668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Applied Radiation and Isotopes"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.apradiso.2025.111825","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T03:23:19Z","timestamp":1744255399000},"page":"111825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Optimization of synthesis conditions of [68Ga]Ga-PSMA-D5 and its clinical application in prostate cancer"],"prefix":"10.1016","volume":"221","author":[{"given":"Kaixuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingxing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jikui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.apradiso.2025.111825_bib1","doi-asserted-by":"crossref","first-page":"79s","DOI":"10.2967\/jnumed.115.170720","article-title":"The rise of PSMA ligands for diagnosis and therapy of prostate cancer","volume":"57","author":"Afshar-Oromieh","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2025.111825_bib2","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s00259-017-3711-7","article-title":"Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET\/CT in patients with recurrent prostate cancer: evaluation in 1007 patients","volume":"44","author":"Afshar-Oromieh","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"10071","key":"10.1016\/j.apradiso.2025.111825_bib3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"PROMIS study group. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.apradiso.2025.111825_bib4","doi-asserted-by":"crossref","first-page":"7645","DOI":"10.1158\/1078-0432.CCR-11-1357","article-title":"2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer","volume":"17","author":"Chen","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"18","key":"10.1016\/j.apradiso.2025.111825_bib5","doi-asserted-by":"crossref","first-page":"13332","DOI":"10.1021\/acs.jmedchem.3c01475","article-title":"Synthesis, preclinical evaluation, and first-in-human PET study of [68Ga]-Labeled biphenyl-containing PSMA tracers","volume":"66","author":"Chen","year":"2023","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.apradiso.2025.111825_bib6","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1021\/bc200279b","article-title":"68Ga-Complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging","volume":"23","author":"Eder","year":"2012","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.apradiso.2025.111825_bib7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.prro.2017.07.011","article-title":"Prostate cancer\u2212specific PET radiotracers: a review on the clinical utility in recurrent disease","volume":"8","author":"Evans","year":"2018","journal-title":"Pract. Radiat. Oncol."},{"issue":"21","key":"10.1016\/j.apradiso.2025.111825_bib8","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1111\/bph.13576","article-title":"The therapeutic and diagnostic potential of the prostate specific membrane antigen\/glutamate carboxypeptidase II (PSMA\/GCPII) in cancer and neurological disease","volume":"173","author":"Evans","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.apradiso.2025.111825_bib9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3390\/ph14050385","article-title":"Standardization of the [68Ga]Ga-PSMA-11 radiolabeling protocol in an automatic synthesis module: assessments for PET imaging of prostate cancer","volume":"14","author":"Fuscaldi","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.apradiso.2025.111825_bib10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s11307-018-1263-2","article-title":"Combined early and late [68Ga]PSMA-HBED-CC PET scans improve lesion detectability in biochemical recurrence of prostate cancer with low PSA levels","volume":"21","author":"Hohberg","year":"2019","journal-title":"Mol. Imag. Biol."},{"issue":"3","key":"10.1016\/j.apradiso.2025.111825_bib11","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1148\/radiol.10092068","article-title":"Dynamic contrast-enhanced CT for prostate cancer: relationship between image noise, voxel size, and repeatability","volume":"256","author":"Korporaal","year":"2010","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.apradiso.2025.111825_bib12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.euo.2023.09.008","article-title":"Digital rectal examination is not a useful screening test for prostate cancer","volume":"6","author":"Krilaviciute","year":"2023","journal-title":"Eur Urol Oncol"},{"issue":"12","key":"10.1016\/j.apradiso.2025.111825_bib13","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.7150\/thno.13348","article-title":"PSMA ligands for radionuclide imaging and therapy of prostate cancer: clinical status","volume":"5","author":"L\u00fctje","year":"2015","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.apradiso.2025.111825_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12916-021-02230-y","article-title":"Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients","volume":"20","author":"Merriel","year":"2022","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.apradiso.2025.111825_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.apradiso.2025.111825_bib16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.urolonc.2013.09.003","article-title":"The prostate-specific membrane antigen: lessons and current clinical implications from 20 years of research","volume":"32","author":"Ristau","year":"2014","journal-title":"Urol. Oncol."},{"issue":"1","key":"10.1016\/j.apradiso.2025.111825_bib17","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.apradiso.2025.111825_bib18","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.apradiso.2025.111825_bib19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.urolonc.2008.04.007","article-title":"PSMA expression in Schwannoma: a potential clinical mimicker of metastatic prostate carcinoma","volume":"27","author":"Wang","year":"2009","journal-title":"Urol. Oncol."},{"issue":"1","key":"10.1016\/j.apradiso.2025.111825_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s13550-020-00740-z","article-title":"Preclinical comparison of four [18F, natGa]rhPSMA-7 isomers: influence of the stereoconfiguration on pharmacokinetics","volume":"10","author":"Wurzer","year":"2020","journal-title":"EJNMMI Res."}],"container-title":["Applied Radiation and Isotopes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804325001708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804325001708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T13:04:39Z","timestamp":1762347879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969804325001708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":20,"alternative-id":["S0969804325001708"],"URL":"https:\/\/doi.org\/10.1016\/j.apradiso.2025.111825","relation":{},"ISSN":["0969-8043"],"issn-type":[{"type":"print","value":"0969-8043"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of synthesis conditions of [68Ga]Ga-PSMA-D5 and its clinical application in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Applied Radiation and Isotopes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apradiso.2025.111825","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111825"}}